Table: Kyorin Pharmaceutical -Q1 group results

Kyorin Pharmaceutical

31/07/2025 07:33

Jul 31 (Reuters)- 
             Kyorin Pharmaceutical Co., Ltd. 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Jun 30, 2025        Jun 30, 2024     Mar 31, 2026 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             30.23               28.42           127.00    
                 (+6.4 pct)          (+2.0 pct)       (-2.4 pct)  
  Operating          2.37                1.15             6.10    
                (+106.0 pct)         (+32.0 pct)      (-51.5 pct) 
  Recurring          2.62                1.42             6.30    
                 (+85.1 pct)         (+32.0 pct)      (-52.3 pct) 
  Net                2.10              885 mln            4.80    
                (+137.1 pct)         (+12.4 pct)      (-47.2 pct) 
  EPS             36.57 yen           15.42 yen        83.55 yen  
  Ann Div                             57.00 yen        57.00 yen  
  -Q2 div                             20.00 yen        20.00 yen  
  -Q4 div                             37.00 yen        37.00 yen  
  
  NOTE - Kyorin Pharmaceutical Co., Ltd.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4569.T